Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


July 29, 2015 7:59 AM ET

Health Care Technology

Company Overview of Definiens AG

Company Overview

Definiens AG provides biomedical image analysis and data mining software solutions for life sciences, tissue diagnostics, and clinical digital pathology markets. It offers Definiens Tissue Studio, a solution for biomarker and morphological profiling in research and drug discovery on tissue samples, as well as detects regions of interest and distinguishes cell types and cell subtypes within target regions across various tissue slides; and Definiens Developer XD, a solution for scientists and image analysis experts to create and validate automated solutions for a range of biomedical image analysis problems. The company also provides Definiens Image Miner, a solution that integrates data mining...

Bernhard-Wicki-Straße 5

Munich,  80339

Germany

Founded in 1994

Phone:

49 89 2311800

Fax:

49 89 23118090

Key Executives for Definiens AG

Chief Executive Officer
Founder, Chief Technology Officer and Director
Chief Financial Officer
Chief Operating Officer
Compensation as of Fiscal Year 2015.

Definiens AG Key Developments

Definiens Releases Biomarker Datafication Services for Oncology Clinical Development

Definiens announced a new suite of Biomarker Datafication Services for oncology clinical development programs. This package of services enables pharmaceutical and biotech companies to gather comprehensive data from their tissue samples which can be used to make critical decisions on drug candidate advancements and assess the potential of companion diagnostics for patient stratification. The Biomarker Datafication Services support data gathering and analysis for researchers working on projects in Exploratory Screening, Pharmacokinetics/Pharmacodynamics, and Companion Diagnostic development. By providing high quality image analysis screening for fast and quantitative measurement, users can receive powerful data output including biomarker expression profiles, biological response to therapy and continuous biomarker readouts, allowing highly advanced decision making and data analysis.

Definiens AG Secures EUR 15 Million Financing for Tissue Phenomics-Based Cancer Diagnostics; Appoints Rainer Strohmenger to the Board of Directors

Definiens AG announced that it has closed a round of financing for EUR 15 million. The round was led by Wellington Partners, a leading pan-European venture capital firm. Gilde Healthcare co-led the financing round and was joined by other existing investors Cipio Partners and TVM Capital in the financing. The new funds will allow Definiens to grow its global business in digital pathology image analysis and expand into digital tissue diagnostics. Major investments will be made in executing the company's Tissue Phenomics strategy, enabling partnerships with leading medical centers and pharmaceutical companies to advance the diagnosis and treatment of cancer. In conjunction with the financing, Dr. Rainer Strohmenger, General Partner and Managing Director for Wellington, will join Definiens' Board of Directors.

Definiens Signs Agreement with Clarient Diagnostic Services, Inc. to Offer Validated Solutions for Routine Clinical Pathology Testing

Definiens announced the signing of an agreement with Clarient Diagnostic Services Inc.- which extends the use of Definiens' automated image analysis software and solutions in Clarient's validated clinical applications for immunohistochemistry testing in breast cancer. Definiens' proprietary Cognition Network Technology(R) is core to automatically classify and quantitate key tissue features as part of Clarient's Scope IA Platform offering to its pathology customers.

Similar Private Companies By Industry

Company Name Region
CLS Laborautomationssysteme GmbH Europe
mediDOK Software-Entwicklungsgesellschaft mbH Europe
VEPRO AG Europe
Digital Medics GmbH Europe
InterComponentWare AG Europe

Recent Private Companies Transactions

Type
Date
Target
Merger/Acquisition
November 4, 2014
--
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Definiens AG, please visit www.definiens.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.